[FAEGRE & BENSON LOGO]
January 6, 2006
BY EDGAR AND OVERNIGHT MAIL
***Confidential Treatment Requested by Faegre & Benson LLP***
United States Securities and Exchange Commission
Mail Stop 7010
100 F Street, N.E.
Washington, DC 20549-7010
- Attention:
- Matt Franker
Staff Attorney- Re:
- Crocs, Inc.
Amendment No. 3 to Registration Statement on Form S-1
File No. 333-127526
Ladies and Gentlemen:
On behalf of our client, Crocs, Inc., (the "Company"), we are pleased to submit this response to the comments of the Staff, as set forth in letters dated October 25, 2005 and November 15, 2005 to Ronald R. Snyder, Chief Executive Officer of the Company, on the registration statement referenced above (the "Registration Statement"), including the prospectus contained therein (the "Prospectus"). This letter should be read in conjunction with the accompanying Amendment No. 3 to the Registration Statement ("Amendment No. 3") which was filed by the Company as of January 9, 2005 with the Commission. The responses set forth below under "Staff Comment Letter Dated November 15, 2005" supersede the Company's response to the Staff dated December 14, 2005. This letter also serves to file via electronic transmission a copy of Amendment No. 3 pursuant to Rule 101(a)(2)(i) of Regulation S-T.
Please note that in addition to responding to the Staff's comments, Amendment No. 3 includes financial information for the nine months ended September 30, 2005. As discussed with Rufus Decker and Nudrat Salik of the Staff on December 22, 2005, certain footnote disclosures have been included with the financial information to describe a restatement of the Company's previously-reported financial results for the three months ended March 31, 2005 and the six months ended June 30, 2005. These disclosures can be found at Note 3 to the Company's Consolidated Financial Statement and pages 39 to 42 of the Prospectus. In addition, Mr. Decker and Ms. Salik requested that the Company provide a reconciliation of certain valuations used in the preparation of the financial information for the nine months ended September 30, 2005, as included in Amendment No. 3, as compared to valuations used in the preparation of the financial information for the six months ended June 30, 2005, as included in prior versions of the Registration Statement. This reconciliation has been provided to the Staff supplementally as Appendix 1.
The supplemental information set forth herein and in the appendices hereto has been supplied by the Company for use in connection with the Staff's review of the responses described below, and all such responses have been reviewed and approved by the Company. For convenience, each of the Staff's consecutively numbered comments is set forth herein, followed by the Company's response (in bold). In this letter, all page references, including those set forth in the Staff's comments, have been updated to refer to the page numbers in Amendment No. 3.
To assist the Staff in reviewing Amendment No. 3, we are delivering by overnight mail to Mr. Franker two copies of this letter, two copies of the appendices hereto, and four bound copies of Amendment No. 3. Two of the copies of Amendment No. 3 have been marked to show changes from Amendment No. 2 to the Registration Statement, as filed with the Commission on October 18, 2005.
Staff Comment Letter Dated October 25, 2005
General
- 1.
- Comment: We reiterate comments 1 and 2 to our letter dated September 9, 2005. Please note that we may have additional comments on this information and that this information needs to be included in any preliminary prospectuses you use.
Response: To assist the Staff in reviewing the Registration Statement, information on the price range currently expected for the offering is provided in the supplemental material submitted herewith as Appendix 3. The Company expects to finalize the estimated price range in consultation with the underwriters following the filing of Amendment No. 3, and to include an estimated price range and the maximum number of shares to be sold in this offering in the next amendment to the Registration Statement. In any event, the Company will include estimates of the price range and the maximum number of shares to be sold in this offering in the preliminary prospectus that is first circulated to potential investors, and all other non-Rule 430A information will be included in such preliminary prospectus as well.
Rick Factors, page 10
We depend on a limited number of suppliers…, page 16
- 2.
- Comment: Please expand your discussion of your internal production of proprietary closed-cell resin to state whether this production will affect your performance in your Supply Agreement with Finproject, S.p.A.
Response: The Company will continue to purchase the minimum quantities specified in the Supply Agreement with Finproject, S.p.A. notwithstanding the Company's internal production of proprietary closed-cell resin. Accordingly, the Company does not expect that its internal production will affect its performance under the Supply Agreement. Explanation of this point on page 16 would tend to mitigate the risk factor described on that page, which the Company believes is inappropriate in the risk factors section. The Company has clarified on page 58 that it will continue purchasing the minimum requirements under the Supply Agreement from Finproject, notwithstanding its sourcing of proprietary closed-cell resin from other producers and in-house production.
If we are unable to establish and protect our trademarks…, page 19
- 3.
- Comment: Please clarify that your trademark registration applications in the United States, Brazil, China, Israel, and South Africa are currently pending, consistent with your disclosure on page 60.
Response: The Company has made the requested change on page 19.
Principal and Selling Stockholders, page 78
- 4.
- Comment: We note your response to comment 7 of our letter dated October 17 [sic], 2005. Please note that any preliminary prospectus that is circulated must contain the information required by Item 507 of Regulation S-K for each selling shareholder and, for additional selling shareholders who are broker-dealers or affiliates of broker-dealers, the disclosures stated in comments 23 and 24, respectively, of our letter dated September 9, 2005.
Response: The Company has determined a preliminary list of selling stockholders, but has not yet determined the number of shares that will be sold by each selling stockholder. The information required by Item 507, including the identity and number of shares to be sold for each selling stockholder's account, will be included in the preliminary prospectus that is ultimately circulated.
Two selling stockholders are affiliates of broker-dealers; none of the selling stockholders are broker-dealers. The Company has included disclosure on page 91 in response to prior comment 24. The Company will add, to the extent required by Item 507 Regulation S-K, the names of each selling stockholder, the number of shares to be sold by each selling stockholder, and all other information required by Item 507, once the appropriate share amounts and other information have been determined.
Financial Statements of Crocs, Inc.
Statement of Stockholders' Equity (Deficit), page F-5
- 5.
- Comment: We note your response to prior comment 10. Upon your initial filing of the Form S-1, you are deemed to be a public company for purposes of compliance with the Staff Accounting Bulletins. Please revise your financial statements to reclassify your accumulated losses to additional paid-in capital as of the date you converted from a limited liability company to a C corporation in accordance with SAB Topic 4:B.
Response: The financial statements included in Amendment No. 3 reflect the requested reclassification. These disclosures appear in Note 3 to the Consolidated Financial Statements and in pages 39 to 42 of the Prospectus.
Comments 6 through 12 in the Staff Comment Letter Dated October 25, 2005 were responded to on November 3, 2005.
Staff Comment Letter Dated November 15, 2005
Note 14. Equity, page F-26.
- 1.
- Comment: We note your response to prior comment 6. Given that your response to prior comment 8 states that you began to consider the possibility of an IPO in the fall of 2004, it is not clear how it was determined that a 20% discount for lack of marketability was appropriate at January 1, 2005. Please advise.
Response: As part of the December 31, 2004 valuation which was previously provided to the Staff, Clifton Gunderson LLP ("Clifton") performed a study to determine an appropriate discount for lack of marketability (see pages 37-44 of that valuation). In this analysis, Clifton reviewed current initial public offerings for high growth companies. Included in the analysis was an assumption that the stock would not be marketable for 1.33 years (e.g., the expected time until the completion of the IPO plus a lock-up period). The result was a lack of marketability discount of approximately 20%. Clifton also considered the other studies of private companies before IPOs and restricted stock studies that suggest ranges of 30%-40% for this discount. Accordingly, management believes a 20% lack of marketability discount was reasonable.
- 2.
- Comment: Please tell us more about the discount for lack of control. Specifically address the following:
- •
- Tell us whether the controlling and minority shareholders receive proportionate returns. If so, tell us how you determined it is appropriate to use a discount for lack of control. Refer to Todd E. Hardiman's speech on December 6, 2004 at the 2004 Thirty-Second AICPA National Conference on Current SEC and PCAOB Developments.
- •
- Provide a detailed explanation as to how Clifton arrived at the initial 15% discount to be taken; and
- •
- Explain the specific facts and circumstances that led Clifton to reduce this discount to 10% at August 1, 2004 and then further reduce this discount to 7.5% at September 1, 2004.
Response: The Company has reviewed the speech by Todd E. Hardiman on December 6, 2004. Management has accordingly removed the discounts for lack of control from all valuations. See the further discussion and revised valuations in the response to comment 3 below.
- 3.
- Comment: We continue to have difficulty understanding how your common stock value increased from $790 per share at May 1, 2005 to an estimated pre-stock split IPO range per share of $4,060 to $4,640, which represents an increase in value of 414% to 487% in an approximately six month period. We also continue to have difficulty understanding how your common stock value increased from $1,670 at September 1, 2005 to an estimated pre-stock split IPO range per share of $4,060 to $4,640, which represents an increase in value of 143% to 178%. In order for us to further understand your analysis of Clifton's valuations compared to the projected IPO price, please address the following regarding your hypothetical valuation to test the reasonableness of Clifton's methodologies:
- •
- Tell us the estimated impact of each significant change in assumption on your estimated hypothetical per share value of your common stock;
- •
- Explain to us how the small stock premium and company-specific premium were reflected in the valuations performed by Clifton;
- •
- Explain to us how and why you incorporated the Price-Projected Earnings and MVIC/Projected EBIT in the hypothetical valuation considering that they were not used in the valuations performed by Clifton; and
- •
- Provide us with a summary of your hypothetical valuation, which should show how you arrived at the $3,900 per share value.
Response: In response to the Staff's comment, the Company has revised the valuations at December 31, 2004, May 1, 2005, June 30, 2005, August 1, 2005 and September 1, 2005. The Company has also performed a valuation at October 1, 2005 using the same methodology. These revised valuations and the new October valuation can be found in Appendix 1 in the materials provided supplementally with this letter. The Company believes the effect of the change to the valuation at December 31, 2004 is not significant. Accordingly, management believes the original value is still a reasonable estimate of the value of the Company's equity at that date. Please note that the underwriters have revised their estimates for the price range of the Company's stock in the IPO to $3,035 to $3,502 ($12.99 to $14.99 post-split), and this adjusted price range has been included in the revised estimates for August 1, September 1 and October 1. Further discussion of the adjusted ranges is included below.
As a result of these revisions, stock options granted after December 31, 2004 will have an intrinsic value and the Company will record compensation expense related to such grants. This compensation expense is reflected in amendment No. 3 to the Registration Statement. The following table shows the difference in the original valuation and the revised valuation for the equity value per share for all valuations:
| Pre-Split Value Per Share of Equity | Post-Split Value Per Share of Equity | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Date | ||||||||||||||||||
Original | Revised | Difference | Original | Revised | Difference | |||||||||||||
12/31/2004 | $ | 398 | $ | 408 | $ | 10 | $ | 1.70 | $ | 1.75 | $ | 0.05 | ||||||
5/1/2005 | 790 | 1,381 | 591 | 3.38 | 5.91 | 2.53 | ||||||||||||
6/30/2005 | 1,160 | 2,076 | 916 | 4.97 | 8.89 | 3.92 | ||||||||||||
8/1/2005 | 1,330 | 2,686 | 1,356 | 5.69 | 11.50 | 5.81 | ||||||||||||
9/1/2005 | 1,670 | 2,858 | 1,188 | 7.15 | 12.23 | 5.08 | ||||||||||||
10/1/2005 | N/A | 2,972 | — | N/A | 12.72 | — |
Assumption Changes
A summary of the assumptions that were revised as a result of management's review of the calculations and the Staff's specific comments are discussed below.
Discount for Lack of Control
The Company eliminated the discount for lack of control for all periods in accordance with the SEC speech referenced by the Staff in comment 2.
| Minority Interest Discount | ||||
---|---|---|---|---|---|
Date | |||||
Original | Revised | ||||
12/31/2004 | 15.0 | % | 0 | % | |
5/1/2005 | 15.0 | % | 0 | % | |
6/30/2005 | 15.0 | % | 0 | % | |
8/1/2005 | 10.0 | % | 0 | % | |
9/1/2005 | 7.5 | % | 0 | % | |
10/1/2005 | N/A | 0 | % |
Size Premium
In its revised valuations, the Company revisited the size premium used in the discounted cash flow model. As discussed in the December 31, 2004 valuation, financial studies have shown that, in general, investors require an additional premium for investing in the stocks of "smaller" companies. Based on statistics published by Ibbotson Associates, empirical evidence suggests that the actual returns for smaller companies (i.e., companies with market capitalizations of approximately $100 million) generally exceed the returns for larger companies by 640 basis points. Therefore, for an entity of the approximate size of the Company, the data indicated that an additional risk premium of approximately 6.4% is required in order to determine the value of the Company's equity to potential investors.
The Company has subsequently determined that due to the revised equity valuations, the appropriate size premium needed to be revisited. As a result of increases to the Company's enterprise value, in May the Company moved into the 9th decile of company sizes in the Ibbotson study, and in October moved into the 8th decile of company sizes. The following table shows, for each period, the company size premium assigned to the Company's equity based on the premiums reflected in the Ibbotson study for comparably-sized companies:
| Size Premium | ||||
---|---|---|---|---|---|
Date | |||||
Original | Revised | ||||
12/31/2004 | 6.4 | % | 6.4 | % | |
5/1/2005 | 6.4 | % | 2.9 | % | |
6/30/2005 | 6.4 | % | 2.9 | % | |
8/1/2005 | 6.4 | % | 2.9 | % | |
9/1/2005 | 6.4 | % | 2.9 | % | |
10/1/2005 | N/A | 2.4 | % |
Company-Specific Premium
As discussed in the December 31, 2004 Clifton valuation, a company-specific premium is an additional risk premium in the Capital Asset Pricing Model to account for other risk factors such as non-diversification, financial and operating risks, key man dependence, competition, and other company-specific risk factors. Clifton used the following non-exhaustive list of considerations specific to the Company in assigning the company-specific premium used in its valuation:
- •
- The Company's limited operating history;
- •
- The Company's having no history of profitability;
- •
- The Company's projection of exponential growth in sales from its 2004 levels;
- •
- The footwear industry being susceptible to rapidly changing consumer demands, preferences, and fashion trends;
- •
- Management at the Company as of the December 31, 2004 date of valuation being "thin although experienced"; and
- •
- Even if the Company were to achieve its expected growth in sales, it may not have been able to achieve its projected level of profitability from those sales.
Based on their analysis of the specific factors applicable to the Company, it was Clifton's professional opinion that a company-specific premium of approximately 1000 basis points (10%) was required to be added to the Capital Asset Pricing Model at December 31, 2004.
The company-specific premium has been revised to reflect the gradual progress of the Company towards its IPO and to reflect changes in the risk factors recited above, and other risk factors specific to the Company, over the relevant time periods. As the date of the IPO moved closer, the rate used for the company-specific premium was reduced. The company-specific premium at May 1, 2005 was reduced to 7.5% from 10% at December 31, 2004 as a result of the Company's retention of underwriters in the first quarter of 2005, a significant move towards an eventual IPO. The following table shows the assumption changes made for each period:
| Company-Specific Premium | ||||
---|---|---|---|---|---|
Date | |||||
Original | Revised | ||||
12/31/2004 | 10.0 | % | 10.0 | % | |
5/1/2005 | 10.0 | % | 7.5 | % | |
6/30/2005 | 10.0 | % | 7.5 | % | |
8/1/2005 | 10.0 | % | 5.0 | % | |
9/1/2005 | 10.0 | % | 4.0 | % | |
10/1/2005 | N/A | 3.0 | % |
Terminal Growth Rate
The Company has adjusted the terminal growth rate from 2.5% to 4.5% as management believes that after revisiting their original assumptions, the terminal growth rate of 2.5% (which was believed to approximate inflation) used in the original valuations should be higher to reflect the growth nature of the Company. Accordingly, a terminal growth rate which more closely approximates the expected long-term GDP is being used. The following table shows the assumption changes made for each period:
| Terminal Growth Rate | ||||
---|---|---|---|---|---|
Date | |||||
Original | Revised | ||||
12/31/2004 | 2.5 | % | 4.5 | % | |
5/1/2005 | 2.5 | % | 4.5 | % | |
6/30/2005 | 2.5 | % | 4.5 | % | |
8/1/2005 | 2.5 | % | 4.5 | % | |
9/1/2005 | 2.5 | % | 4.5 | % | |
10/1/2005 | N/A | 4.5 | % |
Treatment of Preferred Shares
As a result of the Staff's comment 6, the Company has clarified the treatment of the preferred shares in the Company's equity valuation. The Company has always included the preference shares in the overall equity value calculation. However, the per share value was only calculated on the equity value of the common shares. The Company has revised the calculation to include a per share value of the Company's equity which includes the preference shares. See Appendix 1 in the materials provided supplementally with this letter for the new calculation.
Guideline Company Method
In the original valuations, the guideline company method was used where multiples from comparable companies during the time period of the valuation were used to determine the value of the Company's equity. Since the Company did not have a history of profitability at the time of the valuation, only the revenue multiple was used. In the revised valuations, management revisited their original estimates. Since the Company was profitable through the three months ended March 31, 2005, management believes it is reasonable to use the EBIT and price earnings multiples as well. The following table shows the assumption changes made for each period:
| MVIC/Revenue Multiple | MVIC/EBIT Multiple | Price/Earnings Multiple | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Date | ||||||||||||
Original | Management | Original | Management | Original | Management | |||||||
12/31/2004 | 1.1 | 1.1 | N/A | N/A | N/A | N/A | ||||||
5/1/2005 | 1.2 | 1.2 | N/A | 7.00 | N/A | 11.00 | ||||||
6/30/2005 | 1.1 | 0.8 | N/A | 7.00 | N/A | 11.00 | ||||||
8/1/2005 | 1.1 | 0.9 | N/A | 10.00 | N/A | 16.00 | ||||||
9/1/2005 | 1.1 | 0.9 | N/A | 8.00 | N/A | 13.00 | ||||||
10/1/2005 | N/A | 0.9 | N/A | 9.00 | N/A | 14.00 |
Methodology
In the original valuations, the Company used its judgment to determine the value of its equity using the Discounted Cash Flow Method, Prior Transaction Method and Guideline Company Method. For the December 31, 2004 valuation, a weighted-average of the three methods was used, putting more emphasis on the Prior Transaction Method due to third-party transactions which occurred shortly after December 31, 2004. For the May 1 and June 30, 2005 valuations, only the Discounted Cash Flow and Guideline Company Methods were used as there were no recent third-party transactions for the Prior Transaction Method. In the revised valuations as of August 1, September 1 and October 1, 2005, the valuation methods used include a method which takes into account the price range provided by the underwriters. See the response to comment 5 for the discussion on how these valuations were determined. The Company also notes to the Staff that the underwriters have revised their estimates for the price range of the Company's stock to $3,035 to $3,502 ($12.99 to $14.99 post-split). The adjusted price range has been included in the revised estimates for August 1, September 1 and October 1. The ranges were changed by the underwriters to reflect lower 2006 projections as provided to the underwriters by management and to reflect a higher multiple range. [***] The underwriters increased the multiples applicable to the projections based on their recent experience in market valuations for similarly-situated companies. See the revised underwriters' valuation at Appendix 3 in the materials provided supplementally with this letter.
- [***]
- Represents redacted material filed separately with the SEC pursuant to a request for confidential treatment made under Rule 418(b) under the Securities Act of 1933, as amended.
Based on the Company's revisions to its assumption and valuation, the hypothetical valuation previously provided by the Company is no longer relevant.
Explanation of Equity Value Increases
The Company believes the revised equity values shown above are reasonable and appropriate. The following discusses the increase in the revised estimates at each date:
December 31, 2004 Value
At December 31, 2004, Clifton used three methods to determine the appropriateness of the equity value of the Company. One of these three methods was the Prior Transaction method. In mid-January 2005, there were third party and related party equity transactions. The value of the equity for each of these transactions was $400 per share ($1.71 per share post-split) which approximated the value determined under both the original and revised valuations above. A schedule of the equity transactions can be found at Appendix 2 in the materials provided supplementally with this letter. Management believes these independent third-party transactions provide an independent verification of the $398 per share ($1.70 per share post-split) value determined at December 31, 2004.
Increase from December 31, 2004 to May 1, 2005
The increase from December 31, 2004 to May 1, 2005 is 247%. The increase is principally a result of revised revenue and net income projections for 2006.
Increase from May 1, 2005 to June 30, 2005
The equity value of the Company increased 50% from May 1, 2005 to June 30, 2005. The increase is principally a result of revised revenue and net income projections for 2006.
Increase from June 30, 2005 to August 1, 2005
The equity value of the Company increased 29% from June 30, 2005 to August 1, 2005. This increase was mainly due to the determination of the underwriter's price range for the Company stock.
Increase from August 1, 2005 to September 1, 2005
The equity value of the Company increased 6% from August 1, 2005 to September 1, 2005. This increase was primarily the result of an IPO becoming more likely and the timing to an IPO becoming shorter as a result of the Company filing the initial Registration Statement during this period.
Increase from September 1, 2005 to October 1, 2005
The equity value of the Company increased 4% from September 1, 2005 to October 1, 2005. This increase was mainly due to the closer proximity to the IPO date.
- 4.
- Comment: We note your response to prior comment 8. You state that in October and November 2004, the CEO and CFO held initial discussions with investment banking firms to learn about the IPO process and IPO price ranges were presented at this time. Tell us the IPO price ranges that were presented at this time. Given that Clifton appears to have arrived at an equity value of $82.0 million at January 1, 2005, help us understand if any consideration was given by Clifton of the enterprise value estimates presented in October and November 2004 of $260 million to $421 million. Please explain who arrived at these enterprise value estimates as well as the method used to arrive at these estimates.
Response: The response to prior comment 8 should be clarified. The Company was provided with ranges of possible enterprise values and possible offering proceeds. However, no price ranges were presented as this time. In performing the Company's valuations, Clifton considered the possibility of an IPO in its assumptions used. The ranges of IPO enterprise values were not specifically taken into account, however, because the valuations provided were based on marketing materials created by the investment banking firms to generate business. The basis for these enterprise values was only a very high-level projection for 2005 net income provided by management of the Company. The firms providing the enterprise value ranges had performed no due diligence on the Company and had very limited financial information from which to estimate a range of values. The firms multiplied the projections by a wide range of multiples seen in the market for both high-growth companies and retail companies. The ranges were simply too wide, and insofar as they were included in marketing materials, were too speculative and not sufficiently objective, to justify reliance on the information. Accordingly, Clifton assigned little weight on these presentations and the values contained therein. Clifton relied on their Guideline Company Method to provide similar company valuation comparisons.
- 5.
- Comment: We note your response to prior comment 9. In your response to comment 49 in your letter dated September 27, 2005 as well in Appendix 4 of your letter dated September 27, 2005, you indicate that the valuations as of July 31, 2005, August 31, 2005, and September 30, 2005 were in process. Given that the estimated price range of $4,060 to $4,640 on a per share pre-stock split basis was provided by the underwriters to you on September 23, 2005 and this estimated price range was provided in your response dated September 27, 2005, it appears that Clifton was aware of the estimated price range at the time of performing their valuations as of August 1, 2005 and September 1, 2005. It is unclear why Clifton would not have taken this estimated price range into consideration in performing these valuations. Please advise.
Response: In the valuations for August 1, 2005 and September 1, 2005, Clifton held their valuation methodology consistent with prior valuations. The IPO price range was only considered in the discount for lack of marketability and company-specific premium but no where else in the original models. In the revised valuations, the Company has included the IPO price range in all valuations commencing with the August 1, 2005 valuation. A probability-weighted factor of 80% for the August 1 and September 1 valuations was used as this is believed to be the best estimate of the probability of the offering at these dates. A probability weighted factor of 90% for the October 1 valuation was used as this is believed to be the best estimate of the probability of the offering at this date. The Company has used the mid-point of the current IPO price range in these calculations.
- 6.
- Comment: We note your response to prior comment 10. You state that you use the probability-weighted expected returns method to value your Series A preferred stock. Given that this method involves a forward-looking analysis of the possible future outcomes, it is unclear whether the
possible conversion of Series A preferred stock to your common stock was considered in your valuation. Please advise.
Response: As discussed in the Company's response to comment 3, the Company adjusted the valuation methodology in response to the Staff's comments to value all of the Company's equity and not exclude the preference shares from the per share equity value. See the revised valuations at Appendix 1 in the materials provided supplementally with this letter.
If we can facilitate the Staff's review of Amendment No. 3, or if the Staff has any questions on any of the information set forth herein, please telephone me at (303) 607-3649, Nate Ford at (303) 607-3662, or Mike McGawn at (303) 607-3664. Any of us may also be reached toll-free at (800) 525-2086. Our fax number is (303) 607-3600. Thank you again for your prompt.
Very truly yours, | ||||
FAEGRE & BENSON LLP | ||||
By: | /s/ JEFFREY A. SHERMAN Jeffrey A. Sherman |
- cc:
- Nudrat Salik, Mail Stop 0306
Ronald R. Snyder, Crocs, Inc.
Caryn D. Ellison, Crocs, Inc.
R. Gregory Spiers, Deloitte & Touche LLP
Securities and Exchange Commission, Document Control